ZDHHC23 and glioblastoma: Moreover, the receiver operating characteristic curve further showed sensitivity of ZDHHC18 as a marker in distinguishing patients with GBM exhibiting mesenchymal subtype from those with non-mesenchymal subtype (Fig. 2d), and that of ZDHHC23 as a marker of proneural subtype (Fig. 2g).